Journals / Göztepe Tıp Dergisi / 2008 / Cilt: 23 - Sayı: 1

Prognostic risk factors in patients with neutropenia

Febril nötropeni olgularında mortaliteyi etkileyen bağımsız değişkenler

Pages
6–9
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

From multivariate logistic regression analysis of patients, we didn' t found independent predictors for mortality.Conclusions: Although renal dysfunction is more frequent in patients with neutropenia and fever who have died than survived, nonindependent predictor for mortality was found.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: The goal of this study was to identify prognostic risk factors present at the beginning of the episode in patients with neutropenia and fever admitted to our hospital.Methods: Twentytwo patients with neutropenia and fever (neutrophils 38,5°C) admitted to our hospital between the years 2005 and 2006 were included in a retrospective study.
📊
Key Findings & Data:We investigated the predictive value of age, gender, the time from the beginning of fever to admission, the presence of malignity as a underlying comorbidity, baseline neutrophil count, the presence of renal dysfunction, elevation in aminotransferase levels, isolation of etiologic organism, the presence of a clinical site of infection, the presence of hypotension, and initial antibiotic preference on mortality in patients with neutropenia and fever.Results: Eightysix per cent of patients had solid tumors and 14 % of patients were not associated with chemotherapy.
💡
Conclusion & Impact:From multivariate logistic regression analysis of patients, we didn' t found independent predictors for mortality.Conclusions: Although renal dysfunction is more frequent in patients with neutropenia and fever who have died than survived, nonindependent predictor for mortality was found.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Aims: The goal of this study was to identify prognostic risk factors present at the beginning of the episode in patients with neutropenia and fever admitted to our hospital.Methods: Twentytwo patients with neutropenia and fever (neutrophils 38,5°C) admitted to our hospital between the years 2005 and 2006 were included in a retrospective study. We investigated the predictive value of age, gender, the time from the beginning of fever to admission, the presence of malignity as a underlying comorbidity, baseline neutrophil count, the presence of renal dysfunction, elevation in aminotransferase levels, isolation of etiologic organism, the presence of a clinical site of infection, the presence of hypotension, and initial antibiotic preference on mortality in patients with neutropenia and fever.Results: Eightysix per cent of patients had solid tumors and 14 % of patients were not associated with chemotherapy. Overal mortality was 13 %. In univariate analysis, renal dysfunction were associated with mortality in patients with neutropenia and fever. From multivariate logistic regression analysis of patients, we didn' t found independent predictors for mortality.Conclusions: Although renal dysfunction is more frequent in patients with neutropenia and fever who have died than survived, nonindependent predictor for mortality was found.

Özet

Amaç: Bu çalışmanın amacı febril nötropenili olgularda mortaliteyi belirleyen başvurudaki risk faktörlerini değerlendirmektir.Gereç ve Yöntem: Bu geriye dönük çalışmaya 2005 ve 2006 yılları arasında hastanemize başvuran ateş ve nötropenisi olan (nötrofil 38,5°C) 22 hasta alındı. Bu çalışmada yaş, cinsiyet, ateşin başlangıcından başvuruya kadar geçen süre, altta yatan malignite varlığı, başlangıç mutlak nötrofil sayısı, renal fonksiyon bozukluğu, aminotransferaz düzeylerinde yükselme, etken mikroorganizmanın izole edilmiş olması, infeksiyon yerinin lokalize edilmiş olması, hipotansiyon varlığı ve başlangıçta seçilen antibiyotik rejimi türünün febril nötropenik olgularda mortalite üzerindeki belirleyici etkisini inceledik.Bulgular: Olguların % 86'sında solid tümör ve kemoterapi öyküsü vardı ve % 14 olgu kemoterapi ile ilişkili değildi. Febril nötropenide mortalite % 13'dü. Renal fonksiyon bozukluğu tek yönlü analizde mortalite ile ilişkiliydi. Ancak çok değişkenli analizde mortaliteyi belirleyen bağımsız değişken bulunamadı.Sonuç: Her ne kadar febril nötropenik olup ölümle sonuçlanan olgularda renal fonksiyon bozukluğu hayatta kalanlara göre daha sık olsa da mortaliteyi belirleyen bağımsız değişken bulunamamıştır.

🔖

Cite This Article

FİNCANCI, M., CEYLAN, B., YÖRÜK, G. (2022). Prognostic risk factors in patients with neutropenia. Göztepe Tıp Dergisi, Cilt: 23 - Sayı: 1, 6–9. https://ajindex.com/articles/526273

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Akova M, Akalın E: Nötropenik hastalarda ateş. Haccettepe Tıp Dergisi 21(1):71-87, 1998
  2. Sausville EA, Longo DE: Principles of cancer treatment: surgery, chemotherapy, and biologic therapy. Harrison’s Principles of Internal Medicine. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (Eds.) NewYork, McGraw-Hill Companies, 2005: 579-580
  3. Sarı R, Bayraktar M, Ayudoğdu İ, et al: Turgut Özal Tıp Merkezi Erişkin Hematoloji Kliniğindeki febril nötropenik ataklarda saptanan infeksiyonların değerlendirilmesi. Turgut Özal Tıp Merkezi Dergisi 7(1):30-33, 2000
  4. Gomez Roca C, Rivero M, Hugo K, et al: Prognostic risk factors for serious complications in an inpatient population with neutropenia at the onset of a febrile episode. Medicina (B Aries) 66(5):385-391, 2006
  5. Paganini HR, Aguirre C, Puppa G, et al: A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer. Cancer 109(12):2572-9, 2007
  6. Akova M: Kanserli, immunosüpresif tedavi alan ve nötropenik hastalarda infeksiyonlar. İnfeksiyon Hastalıkları ve Mikrobiyolojisi. Topçu AW, Söyletir G, Doğanay M (Ed.). İstanbul, Nobel Tıp Kitabevleri Ltd. Sti., 2002: 423-430
  7. Kandemir Ö, Şahin E, Tiftik N, Kaya A: Febril nötropenik kanser hastalarında gözlenen infeksiyonlar ve tedavi başarısını etkileyen faktörlerin değerlendirilmesi. Antibiyotik ve Kemoterapi Dergisi 20(2):98-102, 2006
  8. Giamarellou H: Empirik therapy for infections in the febrile neutropenic, compromised hst. Med Clin North Am 79(3):559-80, 1995
  9. Pizzo FA: Management of fever in patients with cancer and treatment induced neutropenia. N Eng J Med 328(18):1323-38, 1998
  10. Güven GS, Çakır B, Zarakolu P ve ark: Febril nötropenik kanser hastalarında tedavi başarısını etkileyen faktörlerin incelenmesi. Flora Dergisi 9(4):246-251, 2004.